News

Bid to end excessive waiting stands 'no chance' of success

03-Jan-08

The government’s proposals to eliminate excessive waiting from the NHS stand no realistic chance of succeeding, according to a report from an independent think tank.

Civitas blames primary care organisations and GPs in the report Why are we waiting? 

It says the utilisation of independent sector treatment centres is still below capacity despite all the evidence pointing to better standards of care.

It says the number of patients who recalled being offered a choice of hospital for their first outpatient appointment actually fell by 5 per cent between March and July 2007 to 43 per cent.

Just 45 per cent of GP referrals use the Choose and Book system.

James Gubb, director of the Civitas health unit, said: ‘It must now be down to PCTs and GPs to encourage choice and competition. For the benefits of competition to be realised, and for waiting times to really accelerate downwards, the reluctance of commissioners to use independent providers at the expense of established NHS providers has to change.’

neil.durham@haymarket.com

Comment below and tell us what you think

See all commented articles in our Forums and Blogs section

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more